Role of known risk factors in explaining the difference in the risk of coronary heart disease between eastern and southwestern Finland

Annals of Medicine

Volumn 30, Issue 5, 1998, Pages 481-487

  Jousilahti, Pekka ^a   Vartiainen, Erkki ^a   Tuomilehto, Jaakko ^a   Pekkanen, Juha ^a   Puska, Pekka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Coronary heart disease; Epidemiology; Height; Incidence; Risk factors

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FAMILY HISTORY; FINLAND; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; SOCIAL STATUS;

EID: 0031786812     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899809002490     Document Type: Article

References (46)

1. Thom TJ, Epstein FH, Feldman JJ, Leaverton PE, Wolz M. Total Mortality and Mortality from Heart Disease, Cancer and Stroke from 1950 to 1987 in 27 Countries. NIH Publication No. 92-3088. Bethesda, MD: National Institutes of Health; 1992.
2. Manton KG. The global impact of noncommunicable diseases: estimates and projections. World Health Stat Q 1988; 41: 255-66.
3. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas A-M, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583-612.
4. Keys A. Seven Countries. A Multivariate Analyses of Death and Coronary Heart Disease. Cambridge, MA: Harvard University Press; 1980.
5. The Pooling Project Research Group. Relationship of Blood Pressure, Serum Cholesterol, Smoking Habit, Relative Weight and ECG Abnormalities to Incidence of Major Coronary Events: Final Report of the Pooling Project. AHA Monograph No. 60. Dallas: American Heart Association; 1978.
6. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease. Overall findings and differences by age for 316 099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992; 152: 56-64.
7. NIH Consensus Conference. Triglyceride, high-density lipoprotein and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein and Coronary Heart Disease. JAMA 1993; 269: 505-10.
8. Pyörälä K, Laakso M, Uusitupa M. Macrovascular disease in diabetes mellitus. An epidemiologic view. Diabetes Metab Rev 1987; 3: 463-542.
9. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993; 119: 655-60.
10. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-7.
11. Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med 1995; 330: 1549-54.
12. Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JE, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. BMJ 1993; 341: 938-41.
13. Hebert PR, Rich-Edwards JW, Manson JE, et al. Height and incidence of cardiovascular disease in male physicians. Circulation 1993: 88; 1437-43.
14. Pekkanen J, Tuomilehto J, Uutela A, Vartiainen E, Nissinen A. Social class, health behaviour, and mortality among men and women in eastern Finland. BMJ 1995; 311: 589-93.
15. Nyboe J, Jensen G, Appleyard M, Schnohr P. Risk factors for acute myocardial infarction in Copenhagen. I: Hereditary, educational and socioeconomic factors. Eur Heart J 1989; 10: 910-6.
16. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Eng J Med 1993; 328: 1450-6.
17. Salonen JT, Alftan G, Huttunen JK, Pikkarainen J, Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 1982; 2: 175-9.
18. Bosma H, Marmot MG, Hemingway H, Nicholson AC, Brunner E, Stansfeld SA. Low job control and risk of coronary heart disease in Whitehall II (prospective cohort) study. BMJ 1997; 314: 558-65.
19. Perkins KE. Family history of coronary heart disease: is it an independent risk factor? Am J Epidemiol 1986; 124: 182-94.
20. Jousilahti P, Puska P, Vartiainen E, Pekkanen J, Tuomilehto J. Parental history of premature coronary heart disease: an independent risk factor of myocardial infarction. J Clin Epidemiol 1996; 49: 497-503.
21. Menotti A, Keys A, Kromhout D, et al. Inter-cohort differences in coronary heart disease mortality in the 25-year follow-up of the Seven Countries Study. Eur J Epidemiol 1993; 9: 527-36.
22. The World Health Organization MONICA Project. Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. Int J Epidemiol 1994; 23: 505-16.
23. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988; 41: 105-14.
24. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
25. SAS/STAT User's Guide. Version 6, Volumes 1-2, 4th edn. Gary, NC: SAS Institute Inc; 1990.
26. Kannisto V. The Causes of Death as Demographical Factors in Finland (in Finnish with English summary). Kansantaloudellisia tutkimuksia - Economic studies XV. Helsinki, Finland: Kansantaloudellinen yhdistys; 1947.
27. Tuomilehto J, Arstila M, Kaarsalo E, et al. Acute myocardial infarction (AMI) in Finland - baseline data from the FIN-MONICA AMI register in 1983-1985. Eur Heart J 1992; 13: 577-87.
28. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988; 8: 1-21.
29. Stengård JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995; 91: 265-9.
30. Lehtimäki T, Moilanen T, Viikari J, et al. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990; 31: 487-95.
31. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme in a potent risk factor for myocardial infarction. Nature 1992; 359: 641-1.
32. Perola M, Sajantila A, Sarti C, et al. Angiotensin-converting enzyme genotypes in the high- and low-risk area for coronary heart disease in Finland. Genet Epidemiol 1995; 12: 391-9.
33. Koivisto UM, Turtola H, Aalto-Setälä K, et al. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland. J Clin Invest 1992; 90: 219-28.
34. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease. Part 1: Effects of prolonged differences in blood pressure - evidence from nine prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.
35. Viikari J, Rönnemaa T, Seppänen A, et al. Serum lipids and lipoproteins in children, adolescents and young adults in 1980-1986. Ann Med 1991; 23: 53-9.
36. Puska P, Tuomilehto J, Nissinen A, Vartiainen E, eds. The North Karelia Project - 20-Year Results and Experiences. Helsinki, Finland: National Public Health Institute; 1995.
37. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J. Twenty-year trends in coronary risk factors in North Karelia and in other areas in Finland. Int J Epidemiol 1994; 23: 495-503.
38. Virtaranta-Knowles K, Sistonen P, Nevanlinna HR. A population genetic study in Finland: comparison of the Finnish- and Swedish-speaking populations. Hum Hered 1991; 41: 248-64.
39. Puska P. Health promotion challeges for countries of the former Soviet Union: results from collaboration between Estonia, Russian Karelia and Finland. Health Promotion Int 1995; 10: 219-28.
40. Kannam JP, Levy D, Larson M, Wilson PW. Short stature and risk for mortality and cardiovascular disease events. The Framingham Heart Study. Circulation 1994; 90: 2241-7.
41. Liao Y, McGee DL, Cao G, Cooper RS. Short stature and risk of mortality and cardiovascular disease: negative findings from the NHANES I epidemiologic follow-up study. J Am Coll Cardiol 1996; 27: 678-82.
42. Malcolm L. Protein-energy malnutrition and growth. In: Falkner F, Tanner JM, eds. Human Growth 3. Neurobiology and Nutrition. New York: Plenum Press; 1979: 361-72.
43. Eveleth P. Population differences in growth: environmental and genetic factors. In: Falkner F, Tanner JM, eds. Human Growth 3. Neurobiology and Nutrition. New York: Plenum Press; 1979: 373-94.
44. Proos LA. Antropometry in adolescence - secular trends, adoption, ethnic and environmental differences. Horm Res 1993; 39 Suppl 3: 18-24.
45. Kuh DL, Power C, Prodgers B. Secular trends in social class and sex differences in adult height. Int J Epidemiol 1991; 20: 1001-9.
46. Koskinen S. Origins of Regional Differences in Mortality from Ischaemic Heart Disease in Finland. Research Reports 41. Helsinki, Finland: National Research and Development Centre for Welfare and Health; 1995.